Husch M, Sullivan C, Rooney D, et al. Insights from the sharp end of intravenous medication
errors: implications for infusion pump technology. Qual Saf Health Care. 2005;14(2):80-86.
doi: 10.1136/qshc.2004.011957.
Centers for Medicare and Medicaid Services. Fiscal Year (FY) 2016 Results for the CMS
Hospital-Acquired Conditions (HAC) Reduction Program.
https://www.cms.gov/Newsroom/MediaReleaseDatabase/Fact-sheets/2015-Fact-sheets-items/2015-12-10-2.html.
Accessed May 30, 2017.
仅凭处方销售
Teleflex、Teleflex徽标、Arrow、Arrowg+ard Blue Advance和Arrowg+ard Blue Plus是Teleflex
Incorporated或其附属公司在美国和/或其他国家/地区的商标或注册商标。所有其他商标均为其各自所有者的商标。MCI-2020-0466